Amitabh Chandra
@amitabhchandra2
Economist and Professor at HBS and HKS @Harvard. Tweets about food, dogs, piano, affogatos, India, and occasionally, health care.
ID:1087859256
14-01-2013 03:12:47
563 Tweets
19,0K Followers
622 Following
The controversial approval of a new $56,000-a-year #Alzheimers drug against the recommendation of an advisory committee of experts “highlights the importance of having an independent and well-resourced FDA,' says Amitabh Chandra. commonwealthmagazine.org/drug-addiction…
Thank you Chloe East - terrific to work with Amitabh Chandra and Kosali Simon on the manuscript
While FDA review is often described as increasing costs and perhaps slowing flow of new products, by certifying quality, this review can grow market size and innovation incentives, from Benjamin Berger, Amitabh Chandra, and @c_garthwaite nber.org/papers/w28889
I thought health economics deserved its own... let me know what I missed! No shade meant for any of these papers, of course. #healthecon
Original source of comic: xkcd.com/2456/
FDA should have led J&J #covid19 vaccine decision-making, former commissioner Scott Gottlieb, MD writes in The Wall Street Journal. “Putting the issue before the CDC confused the process and slowed the decision.” wsj.com/articles/drug-…
'Imagine if AstraZeneca and Merck were the only ones who had taken up the vaccine challenge...We’d be screwed.”
Dhruv Khullar dazzles in The New Yorker
newyorker.com/science/annals…
“When it comes to something like vaccines, you don’t want the best deal,” he said. “You don’t want to pay the minimum price. You want to overpay and attract the attention of many companies simultaneously.” Amitabh Chandra speaking truth: newyorker.com/science/annals…
3. In JAMA, Justin Grischkan @[email protected] and Amitabh Chandra suggest the best way to fix medical education is to change how it's financed: doi.org/10.1001/jama.2…
Hero work from Margot Sanger-Katz, who combed through the stimulus bill to explain all the new options for health insurance different people will become eligible for.
nytimes.com/2021/03/12/ups…
UM V-BID Center told me that my earlier tweet about the 2021 vbid summit vbidcenter.org/2021-virtual-v… would not get as many likes as the tweet by Patrick Conway. He was right. So I try again by tagging Amitabh Chandra, whose twitter reach dwarfs mine
Matthew E. Kahn To reprise a relevant comment from Don Rubin on this topic: It's easy to signal mathematical aptitude but hard to convey wisdom; we conflate the two, which are not at all the same, even though we care mostly about the latter.
